Investors
News
Contact
Japanese
Global
About
About
Greetings
Mission Statement
Corporate Governance
Management Strategy
ONO Story
Company Overview
Business Activities
History
Main Products
Videos and Advertisements
Policies
Company Profile
Management
Business Locations
ONO Story
R＆D
Manufacturing
Marketing
Safety and Quality Assurance
Digital & IT
ONO’s 300-Year History
CLOSE
ONO Story
Videos and Advertisements
R＆D
R＆D
Our Mission in R&D / Drug Discovery Approach
In-house Drug Discovery
Open Innovation
Licensing Activities
Research Organization
Development Policy
Development Pipeline
The investigator-sponsored research support
CLOSE
Development Pipeline
Global Business
Sustainability
Sustainability
Top Message
ONO's Approach to Sustainability
Environment
Society
Governance
Stakeholder Engagement
Social Contribution Activities
Policies
GRI Standards Content Index
Sustainability Report
ESG Data
External Evaluation
Independent Practitioner's Assurance
Corporate Governance
Compliance
Risk Management
Responsible Promotion Activities
Innovative Pharmaceutical Products
Efforts Made for Improving Access to Healthcare
Respect for Human Rights
Expansion of Human Capital (Talent Development and Employment)
Expansion of Human Capital (Fostering an Organizational Climate and Culture that realizes high employee engagement)
Expansion of Human Capital (Health Management)
Sustainable Procurement
Commitment to Conservation of the Global Environment
Information Disclosure Based on the TCFD Recommendation
Realization of a Decarbonized Society
Realization of a Water Recycling Society
Realization of a Resource Recycling Society
Information Disclosure Based on the TNFD Recommendations
Biodiversity
EHS Management
Environmental Accounting
Stakeholder Engagement
Dialogue with Shareholders and Investors
Cooperation with Governments
ONO’s Social Contribution Activities Global Policy
Efforts for the Advancement of Medicine and Pharmacy
Efforts for Supporting Health of Patients and Their Families
Efforts Toward Environmental Conservation for the Health of Everyone
Efforts Toward an Education for the Children’s Health
Efforts for Improvement of the Medical Ecosystem
CLOSE
ECO VISION 2050
Improving Access to Healthcare
icon_search_white
icon_close_w
Search
About
About
Top
Greetings
Mission Statement
Corporate Governance
Management Strategy
ONO Story
Company Overview
History
Main Products
Videos and Advertisements
Policies
Business Activities
R&D
Manufacturing
Marketing
Safety and Quality Assurance
Digital & IT
R＆D
R＆D
Top
Our Mission in R&D / Drug Discovery Approach
In-house Drug Discovery
Open Innovation
Licensing Activities
Research Organization
Development Policy
Development Pipeline
The investigator-sponsored research support
Global Business
Global Business
Top
Sustainability
Sustainability
Top
Top Message
ONO's Approach to Sustainability
Environment
Society
Governance
Stakeholder Engagement
Social Contribution Activities
Policies
GRI Standards Content Index
Sustainability Report
ESG Data
External Evaluation
Independent Practitioner's Assurance
icon_search_g
Search
Sustainability Report
Sustainability Report
Sustainability Report 2024
Sustainability Report 2024
Sustainability Report 2024 (39.4MB)
For the Corporate Report, please see
here.
Backnumber (PDF)
Backnumber (PDF)
Sustainability Report 2023 (36.6MB)
Sustainability Report 2022 (25.1MB)
CSR Report 2021 (22.2MB)
CSR Report 2020 (18.7MB)
CSR Report 2019 (16.7MB)
CSR Report 2018 (8.22MB)
CSR Report 2017 (5.87MB)
CSR Report 2016 (2.52MB)
CSR Report 2014 (10.5MB)
CSR Report 2013 (2.05MB)
Environmental Report 2012 (40.3KB)
ONO PHARMACEUTICAL CO.,LTD., ONO PHARMACEUTICAL CO.,LTD., system
Otomatik - 18.178.27.243
CloudFlare DNS
Türk Telekom DNS
Google DNS
Open DNS
OSZAR »
